Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on clioquinol in drug-resistant childhood epilepsy
2020-004511-27Phase 2Active
- Sponsor
- UZ Leuven
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Clioquinol in epilepsy, sponsored by UZ Leuven. Primary endpoint: Efficacy of clioquinol on seizure frequency and severity. Started Jan 2021; status: active.
02
Drugs
Clioquinol
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2020-004511-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004511-27.